The health-care industry is getting into the weed business.
Several industry players announced or closed deals in May involving companies that produce cannabis or hemp used to make medical products, according to a list of select transactions compiled for Bloomberg Law by investment bankers at ECG Management Consultants and Provident Healthcare Partners LLC.
These companies are attracting mainstream investors due to their potential to generate high earnings now that their products are legal in many states, at least for medical purposes, Gary W. Herschman, a member of Epstein Becker & Green in Newark, N.J., told Bloomberg Law.
But marijuana ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.